The risks and benefits of antidepressant treatment for youth depression
Open accessThe DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
The U.S. Food and Drug Administration (FDA) has mandated that all antidepressants carry a 'black box' warning label indicating that antidepressants increase the risk of suicidality in youth taking these medications. In the U.K., the Medicine and Healthcare Products Regulatory Agency (MHRA) has determined that the balance of risks and benefits favors only the use of fluoxetine in the treatment of depressive illness in children and adolescents. This article reviews the FDA's analysis linking antidepressant medication use and pediatric suicidality in major depressive disorder, discusses the efficacy of antidepressants in treating depression in children and adolescents, and offers suggestions to aid clinicians, patients, and families in making clinical decisions based on an accurate assessment of the benefits and risks of medication and psychosocial treatments for pediatric depression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Toward a clinical model of suicidal behavior in psychiatric patients
Mann, J. J., Waternaux, C., Haas, G. L., & Malone, K. M. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.2.181 · Cited by 1,791 · cited 1×
“Several lines of research demonstrate an association between impulsive aggression and suicidal behavior (9,10).”
BackgroundBrent, D. A. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830210125017 · Cited by 753 · cited 1×
“Although cognitive-behavioral therapy (CBT) appears to be more effective than some other psychosocial treatments for depression (39,45), the only study that compared therapy to medication found CBT inferior to fluoxetine therapy (8).”
BackgroundSelf-citationAdolescent suicidal ideation and attempts: Prevalence, risk factors, and clinical implications.
Lewinsohn, P. M., Rohde, P., & Seeley, J. R. (1996) · Clinical Psychology: Science and Practice · doi:10.1111/j.1468-2850.1996.tb00056.x · Cited by 661
KELLER, M. B., RYAN, N. D., STROBER, M., KLEIN, R. G., KUTCHER, S. P., BIRMAHER, B., HAGINO, O. R., KOPLEWICZ, H., CARLSON, G. A., CLARKE, G. N., et al. (2001) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200107000-00010 · Cited by 641 · cited 5×
“Finally, we did not include older antidepressants (e.g. TCAs, monoamine oxidase inhibitors (MAOIs)) in our review, as the FDA analysis focused only on the newer classes of antidepressants.”
ResultInfluentialSelf-citationEfficacy of interpersonal psychotherapy for depressed adolescents
Mufson, L. (1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.6.573 · Cited by 552 · cited 1×
“While there is growing evidence supportive of IPT as a treatment for moderate depression in adolescents, IPT has never been compared to medication (40,41).”
A Randomized Effectiveness Trial of Interpersonal Psychotherapy forDepressed Adolescents
Mufson, L., Dorta, K. P., Wickramaratne, P., Nomura, Y., Olfson, M., & Weissman, M. M. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.6.577 · Cited by 537 · cited 1×
“While there is growing evidence supportive of IPT as a treatment for moderate depression in adolescents, IPT has never been compared to medication (40,41).”
Venlafaxine and paroxetine in treatment-resistant depression: Double-blind, randomised comparison
Poirier, M.-F., & Boyer, P. (1999) · British Journal of Psychiatry · doi:10.1192/bjp.175.1.12 · Cited by 185 · cited 1×
“Studies of adults have shown the superiority of venlafaxine to active medication and placebo for patients who have already failed to respond to one SSRI (34-37) and among patients with concomitant depression and anxiety (38), with no differences in the rates of adverse events and side effects.”
BackgroundReview of the efficacy and safety of antidepressants in youth depression
Cheung, A. H., Emslie, G. J., & Mayes, T. L. (2005) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.2005.01467.x · Cited by 183
Valuck, R. J., Libby, A. M., Sills, M. R., Giese, A. A., & Allen, R. R. (2004) · CNS Drugs · doi:10.2165/00023210-200418150-00006 · Cited by 182
Cited by
The Continuing Shortage of Child and Adolescent Psychiatrists
THOMAS, C. R., & HOLZER, C. E. (2006) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000225353.16831.5d · Cited by 365
Guidelines for Adolescent Depression in Primary Care (GLAD-PC): II. Treatment and ongoing management
Cheung, A. H., Zuckerbrot, R. A., Jensen, P. S., Ghalib, K., Laraque, D., Stein, R. E. K., & and the GLAD-PC Steering Group (2007) · Pediatrics · doi:10.1542/peds.2006-1395 · Cited by 336
Cheung, A. H., Zuckerbrot, R. A., Jensen, P. S., Laraque, D., Stein, R. E. K., GLAD-PC STEERING GROUP, Levitt, A., Birmaher, B., Campo, J., Clarke, G., et al. (2018) · Pediatrics · doi:10.1542/peds.2017-4082 · Cited by 299
Self-citationDecline in Treatment of Pediatric Depression After FDA Advisory on Risk of Suicidality With SSRIs
Libby, A. M., Brent, D. A., Morrato, E. H., Orton, H. D., Allen, R., & Valuck, R. J. (2007) · American Journal of Psychiatry · doi:10.1176/ajp.2007.164.6.884 · Cited by 281
Self-citationMaintenance study for adolescent depression
Cheung, A., Kusumakar, V., Kutcher, S., Dubo, E., Garland, J., Weiss, M., Kiss, A., & Levitt, A. (2008) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2008.0001 · Cited by 44
Metadata
- Authors
- Bridge, J. A., Salary, C. B., Birmaher, B., Asare, A. G., & Brent, D. A.
- Venue
- Annals of Medicine
- Publisher
- Informa UK Limited
- Published
- 2005-01
- Volume
- 37
- Issue
- 6
- Pages
- 404-412
- ISSN
- 0785-3890 (ISSN-L)
- 1365-2060
- OpenAlex
- W2122506446
- Cited by
- 53
- References
- 13
- FWCI
- 3.63
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The risks and benefits of antidepressant treatment for youth depression. https://app.cochat.ai/papers/10.1080/07853890500284937
- The paper
- Bridge, J. A., Salary, C. B., Birmaher, B., Asare, A. G., & Brent, D. A. (2005). The risks and benefits of antidepressant treatment for youth depression. Annals of Medicine. https://doi.org/10.1080/07853890500284937
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.